Bridgepoint Group (LON:BPT) Stock Price Up 0.2% – Should You Buy?

Bridgepoint Group plc (LON:BPT)’s share price rose 0.2% on Monday . The stock traded as high as GBX 243.40 and last traded at GBX 243.40. Approximately 677,410 shares changed hands during trading, a decline of 88% from the average daily volume of 5,888,479 shares. The stock had previously closed at GBX 242.97.

Wall Street Analysts Forecast Growth

Separately, JPMorgan Chase & Co. boosted their target price on Bridgepoint Group from GBX 395 to GBX 415 and gave the stock a “buy” rating in a report on Monday, January 5th. Two research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. According to MarketBeat, Bridgepoint Group has a consensus rating of “Moderate Buy” and a consensus target price of GBX 385.

Bridgepoint Group Stock Up 0.2%

The company has a market capitalization of £2.13 billion, a PE ratio of 49.67, a price-to-earnings-growth ratio of 0.61 and a beta of 1.35. The company has a quick ratio of 3.60, a current ratio of 279.03 and a debt-to-equity ratio of 55.04. The firm has a 50-day moving average of GBX 244.64 and a two-hundred day moving average of GBX 273.87.

Bridgepoint Group (LON:BPT) last issued its quarterly earnings data on Thursday, March 12th. The company reported GBX 26.50 earnings per share for the quarter. Bridgepoint Group had a return on equity of 4.25% and a net margin of 7.68%. Equities research analysts predict that Bridgepoint Group plc will post 17.4062165 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Bridgepoint Group news, insider Michelle Scrimgeour acquired 21,616 shares of the stock in a transaction that occurred on Thursday, March 12th. The stock was bought at an average cost of GBX 230 per share, for a total transaction of £49,716.80. Insiders own 0.60% of the company’s stock.

About Bridgepoint Group

Bridgepoint Group plc is a private equity and private credit firm specializing in middle market, small mid cap, small cap, growth capital, buyouts investments, syndicate debt, infrastructure, direct lending and credit opportunities in private credit investments. It prefers to invest in advanced industrials, automation, agricultural sciences, energy transition enablers, business services, financial services, professional services, testing inspection and certification, information services, consumer, digital brands, video games, wellbeing products, health care, pharma and MedTech outsourced services, pharma products, and MedTech Products sectors.